Form 4: Emergent BioSolutions Director Kathryn C. Zoon Sells 10,000 Shares
SEC Form 4 Filing
Director Kathryn C. Zoon sold 10,000 shares of Emergent BioSolutions Inc. (EBS) at $6.11 per share on June 4, 2024.
Summary
- Kathryn C. Zoon, a director of Emergent BioSolutions Inc., sold 10,000 shares of common stock on June 4, 2024.
- The sale price was $6.11 per share.
- Following the transaction, Zoon directly owns 54,482 shares of Emergent BioSolutions Inc.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock sale by a company director. It doesn't inherently indicate positive or negative sentiment about the company's future prospects.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, buys or sells shares of their company's stock. It provides transparency to the market regarding insider transactions.
Stakeholder Impact
- The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the director's reasons for selling.
Key Dates
| Date | Description |
|---|---|
| 06/04/2024 | Date of stock sale transaction. |
| 06/06/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.